All terms
Quality & RiskQuality System
Biocompatibility
Ability of a material to perform with an appropriate host response in a specific application.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
Biocompatibility evaluates how a medical device material interacts with the human body to ensure it does not produce adverse biological responses such as cytotoxicity, sensitization, or systemic toxicity. What the regulation says
Regulators like the FDA and notified bodies under the EU MDR emphasize biocompatibility as a critical aspect of patient safety. ISO 10993 series is the primary standard for evaluating the biological effects of medical devices, offering a framework for risk management in this area. Manufacturers must demonstrate that their devices do not pose unacceptable biological risks throughout their lifecycle, as outlined in requirements like EU MDR Annex I, Chapter I, Section 10.1.What this means in practice
Tests are selected per ISO 10993-1 based on contact category and duration. Material changes typically trigger re-evaluation.Examples
- A manufacturer of a new cardiovascular stent must conduct extensive biocompatibility testing, including hemocompatibility, due to its direct and prolonged contact with blood.
- Before introducing a new adhesive in the assembly of a wound dressing, a company must re-evaluate the dressing's biocompatibility, focusing on potential skin sensitization and irritation.
- An orthopedic implant manufacturer must assess the long-term biological response, including degradation product analysis, for their device due to its permanent implantation within the body.
Common pitfalls
- •Failing to consider the entire manufacturing process and all constituent materials when assessing biocompatibility is a common mistake.
- •Assuming prior biocompatibility data for a material is sufficient without considering its processing or final device application can lead to non-compliance.
- •Neglecting to re-evaluate biocompatibility after intended changes to material suppliers, manufacturing processes, or sterilization methods is a significant pitfall.
- •Not adequately addressing extractables and leachables profiles can result in incomplete biocompatibility assessments.
- •Ignoring the potential for long-term biological effects for permanently implanted devices is a serious oversight.
Frequently asked questions
The ISO 10993 series of standards, particularly ISO 10993-1, provides a comprehensive framework for biological evaluation of medical devices. It guides the selection of appropriate tests based on the nature and duration of device contact with the body.
Related terms
Shared paths + categoryStandards
ISO 10993-1
Biological evaluation of medical devices within a risk management process.
Manufacturing & Supply Chain · adjacent
Quality & Risk
Change Control
Formal QMS process for evaluating, approving, and implementing changes that could affect product quality or compliance.
Manufacturing & Supply Chain
Manufacturing
Cleanroom Classes (ISO 14644)
ISO 14644 classification of cleanrooms by airborne particulate cleanliness (ISO 1 through ISO 9).
Manufacturing & Supply Chain · adjacent
Quality & Risk
IQ / OQ / PQ
Installation, Operational, and Performance Qualification - the three stages of equipment and process qualification.
Manufacturing & Supply Chain
Quality & Risk
Nonconformance (NCR)(NCR)
Failure of a product, process, or system to meet specified requirements.
Manufacturing & Supply Chain
Quality & Risk
Shelf Life
Period during which a device remains suitable for its intended use under specified conditions.
Manufacturing & Supply Chain
Latest in MedTech
Primary references
3 sourcesLink health: 3 verified· last checked 2026-06-20
FDA·2ISO·1
- 1FDA Biocompatibility GuidanceVerifiedFDAfda.gov
- 2FDA - Quality SystemsVerifiedFDAfda.gov
- 3ISO 13485 Standard PageVerifiedISOiso.org
Inline markers like [1] jump to the matching reference above.